Shimada A, Ikegami H:
Twenty years since the discovery of fulminant type 1 diabetes
Diabetol Int. 11: 309, 2020

Ikegami H, Imagawa A, Shimada A: 
Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000.
Diabetol Int. 11: 342-343, 2020

Kawabata Y, Ikegami H:
Genetics of fulminant type 1 diabetes.
Diabetol Int. 11: 315-322, 2020

Babaya N, Noso S, Hiromine Y, Taketomo Y, Niwano F, Yoshida S, Yasutake S, Kawabata Y, Ikegami H:
Flash glucose monitoring in type 1 diabetes: A comparison with Self-monitoring blood glucose.
J Diabetes Investig. 11:1222-1229, 2020

Yoshida Y, Kashiwabara K, Matsuyama Y, Hirakawa Y, Tanaka T, Nangaku M, Noso S, Ikegami H, Ohsugi M, Ueki K, Mita T, Watada H, Koya D, Wada J, Shimizu M, Wada T, Ito Y, Narita I, Kashihara N:
Conditions, Pathogenesis and Progression of Diabetic Kidney Disease and Early Decliner in Japan.
BMJ Open Diabetes Res Care. 1: e000902, 2020

Kobayashi M, Ueda H, Babaya N, Itoi-Babaya M, Noso S, Fujisawa T, Horio F, Ikegami H:
Type 2 diabetes susceptibility genes on mouse chromosome 11 under high sucrose environment
BMC Genetics 21:81,2020

Sada K, Hidaka S, Imaishi K, Katashima R, Noso S, Ikgeami H, Kakuma T, Shibata H:
Clinical and Genetic analysis in a family with familial renal glucosuria: Identification of an N101K mutation in the sodium-glucose cotoransporter 2 encoded by a solute carrier family 5 member 2 gene.
J Diabetes Investig. 11: 573-577, 2020

Abiru N, Ikegami H, Ueki K. Kaku K, Kadowaki T, Sato S, Seino Y, Haneda M:
Recommendations on the proper use of SGLT2 inhibitors
Diabetol Int. 11: 1-5, 2020

Babaya N, Okuda Y, Noso S, Hiromine Y, Taketomo Y, Niwano F, Ueda K, Tanaka Y, Yamazaki Y, Sasano H, Kawabata Y, Ohno Y, Ikegami H:
A rare case of adrenal cysts associated with bilateral incidentalomas and diffuse hyperplasia of the zona glomerulosa
J Endocr Soc. 5: bvaa184, 2020

 英文

2020/02/04 10:46